BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/07/2020

FDA Releases Draft Guidance on Biomarkers and Surrogate Endpoints for New Animal Drugs

The FDA is releasing a draft guidance document that outlines its current thinking on using biomarkers and surrogate endpoints in clinical studies to support the effectiveness of new animal drugs.

Source: Federal Register — Food and Drug AdministrationOpen original release →